{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:44:53Z","timestamp":1795052693584,"version":"4.10.2"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva, vedy, v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","award":["APVV-20-0421"],"award-info":[{"award-number":["APVV-20-0421"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva, vedy, v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","award":["1\/0048\/23"],"award-info":[{"award-number":["1\/0048\/23"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116391","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T07:50:28Z","timestamp":1710143428000},"page":"116391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effect of sacubitril\/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-4885","authenticated-orcid":false,"given":"Fedor","family":"Simko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1509-3794","authenticated-orcid":false,"given":"Peter","family":"Stanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-1710","authenticated-orcid":false,"given":"Kristina","family":"Repova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Baka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Krajcirovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-0081","authenticated-orcid":false,"given":"Silvia","family":"Aziriova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-8753","authenticated-orcid":false,"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zorad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Adamcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovit","family":"Paulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116391_bib1","first-page":"507","article-title":"Left ventricular hypertrophy regression as a process with variable biological implications","volume":"12","author":"Simko","year":"1996","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00001573-200007000-00010","article-title":"Fibrosis and hypertensive heart disease","volume":"15","author":"Weber","year":"2000","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101867","article-title":"Comparison of International Guidelines for Managing Chronic Heart Failure with Reduced Ejection Fraction","volume":"48","author":"Nabil","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib5","article-title":"Comparison of Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis","volume":"15","author":"Haseeb","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2024.116391_bib6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.250","article-title":"Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances","volume":"17","author":"McMurray","year":"2015","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2024.116391_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116391_bib8","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.hjh.0000388489.28213.08","article-title":"Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril","volume":"28","author":"Simko","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2024.116391_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/703175","article-title":"Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin","volume":"2014","author":"Simko","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2024.116391_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081612","article-title":"Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril","volume":"18","author":"Simko","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116391_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0009-9120(96)00003-6","article-title":"A simplified method for the analysis of hydroxyproline in biological tissues","volume":"29","author":"Reddy","year":"1996","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.biopha.2024.116391_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure","volume":"69","author":"Basu","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and High-renin Heart Failure Phenotypes with Clinical Implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2024.116391_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/HYPERTENSIONAHA.120.14871","article-title":"Effects of Ramipril on the Aldosterone\/Renin Ratio and the Aldosterone\/Angiotensin II Ratio in Patients With Primary Aldosteronism","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116391_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/HYPERTENSIONAHA.119.13772","article-title":"Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116391_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-60761-247-6_8","article-title":"Echocardiographic examination in rats and mice","volume":"573","author":"Liu","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2024.116391_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.978337","article-title":"Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril","volume":"13","author":"Repova","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116391_bib18","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.33549\/physiolres.932592","article-title":"Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24\u2009h light-induced hypertension","volume":"62","author":"Repov\u00e1-Bedn\u00e1rov\u00e1","year":"2013","journal-title":"Physiol. Res"},{"key":"10.1016\/j.biopha.2024.116391_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2741\/4125","article-title":"Experimental models of melatonin-deficient hypertension","volume":"18","author":"Simko","year":"2013","journal-title":"Front Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.biopha.2024.116391_bib20","first-page":"19","article-title":"Impaired nocturnal melatonin secretion in non-dipper hypertensive patients","volume":"12","author":"Jonas","year":"2003","journal-title":"Blood Press"},{"key":"10.1016\/j.biopha.2024.116391_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-079X.2007.00436.x","article-title":"Melatonin as a potential antihypertensive treatment","volume":"42","author":"Simko","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2024.116391_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020509","article-title":"Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions","volume":"23","author":"Reiter","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116391_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120612","article-title":"Melatonin: A mitochondrial resident with a diverse skill set","volume":"301","author":"Reiter","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116391_bib24","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/HYPERTENSIONAHA.107.100032","article-title":"LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling","volume":"50","author":"Paulis","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116391_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-079X.2009.00697.x","article-title":"Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment","volume":"47","author":"Simko","year":"2009","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116391_bib26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/HYPERTENSIONAHA.109.148254","article-title":"Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats","volume":"55","author":"Rezzani","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116391_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jpi.12348","article-title":"Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review","volume":"61","author":"Simko","year":"2016","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.biopha.2024.116391_bib28","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.3390\/ijms232416187","article-title":"Melatonin as a Potential Approach to Anxiety Treatment","volume":"23","author":"Repova","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116391_bib29","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1042\/CS20200922","article-title":"Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists","volume":"134","author":"Steckelings","year":"2020","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.biopha.2024.116391_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/CS20210182","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?","volume":"135","author":"Simko","year":"2021","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.biopha.2024.116391_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842512","article-title":"Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells","volume":"13","author":"Simko","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116391_bib32","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/ijms22063217","article-title":"Renin\u2013Angiotensin\u2013Aldosterone System: Friend or Foe\u2014The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions","volume":"22","author":"Simko","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116391_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020265","article-title":"Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension","volume":"23","author":"Simko","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116391_bib34","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/biomedicines10081844","article-title":"Sacubitril\/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin-Angiotensin-Aldosterone System","volume":"10","author":"Simko","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.116391_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnins.2020.00248","article-title":"Constant Light Exerted Detrimental Cardiovascular Effects Through Sympathetic Hyperactivity in Normal and Heart Failure Rats","volume":"14","author":"Jing","year":"2020","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2024.116391_bib36","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.juro.2013.12.043","article-title":"Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort","volume":"191","author":"Obayashi","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2024.116391_bib37","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCRESAHA.112.300521","article-title":"Role of the ubiquitin proteasome system in the heart","volume":"112","author":"Pagan","year":"2013","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2024.116391_bib38","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1074\/jbc.272.20.13437","article-title":"Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation","volume":"272","author":"Craiu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.116391_bib39","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.hjh.0000388494.58707.0f","article-title":"Effect of nuclear factor kappa B inhibition on L-NAME-induced hypertension and cardiovascular remodelling","volume":"28","author":"Vrankova","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2024.116391_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/HJH.0b013e32834f043b","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress","volume":"30","author":"Mart\u00edn","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2024.116391_bib41","article-title":"Tyrosine hydroxylase is short-term regulated by the ubiquitin-proteasome system in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: possible implications in hypertension","volume":"10","author":"Congo Carbajosa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116391_bib42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s004410051315","article-title":"Sarcomeric myosin heavy chain is degraded by the proteasome","volume":"296","author":"Eble","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.biopha.2024.116391_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.niox.2019.10.007","article-title":"Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension","volume":"94","author":"Sharma","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biopha.2024.116391_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0167-0115(99)00004-X","article-title":"Angiotensin II and aldosterone regulation","volume":"80","author":"Mulrow","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.biopha.2024.116391_bib45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0196-9781(01)00418-1","article-title":"Stimulation of endogenous nitric oxide production is involved in the inhibitory effect of adrenomedullin on aldosterone secretion in the rat","volume":"22","author":"Rebuffat","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2024.116391_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2008020232","article-title":"Aldosterone activates NF-kappaB in the collecting duct","volume":"20","author":"Leroy","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2024.116391_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2024.116391_bib48","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a Mediator of Cardiovascular Damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116391_bib49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib50","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1113\/EP085884","article-title":"New insights into the elucidation of angiotensin-(1-7) in vivo antiarrhythmic effects and its related cellular mechanisms","volume":"101","author":"Joviano-Santos","year":"2016","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.biopha.2024.116391_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijcard.2017.01.071","article-title":"Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure","volume":"236","author":"Zhang","year":"2017","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib52","article-title":"Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1\/Wnt\/\u03b2-Catenin Signaling Pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116391_bib53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.01.077","article-title":"Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction","volume":"258","author":"Kompa","year":"2018","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.biopha.2024.116391_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2024.116391_bib55","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ejhf.474","article-title":"LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice","volume":"18","author":"Suematsu","year":"2016","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2024.116391_bib56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.14740\/cr1137","article-title":"Sacubitril\/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect","volume":"11","author":"Tashiro","year":"2020","journal-title":"Cardiol. Res"},{"key":"10.1016\/j.biopha.2024.116391_bib57","article-title":"Sacubitril\/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116391_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175754","article-title":"Sacubitril\/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats","volume":"952","author":"Li","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116391_bib59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/cancers15010312","article-title":"Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity","volume":"15","author":"Sobiborowicz-Sadowska","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.116391_bib60","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1097\/HJH.0000000000001762","article-title":"Effects of dual angiotensin type 1 receptor\/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat","volume":"36","author":"Rubattu","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2024.116391_bib61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012272","article-title":"Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis","volume":"8","author":"Wang","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2024.116391_bib62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:21:41Z","timestamp":1793787701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224002750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":62,"alternative-id":["S0753332224002750"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116391","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sacubitril\/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116391"}}